According to Future Market Insights research, during the projected period, the Global point-of-care diagnostics market is expected to grow at a CAGR of 6.8%. The market value is projected to increase from USD 38.7 Billion in 2023 to USD 74.8 Billion by 2033. The point-of-care diagnostics market was valued at USD 36.6 Billion at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 5.8% in 2023.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | USD 36.6 Billion |
| Market Value 2023 | USD 38.7 Billion |
| Market Value 2033 | USD 74.8 Billion |
| CAGR 2023 to 2033 | 6.8% |
| Share of Top 5 Countries | 56.5% |
| Key Players | The key players in the Global Point-of-Care Diagnostics Market Are F. Hoffmann-La Roche Ltd; Becton Dickinson & Company; Cepheid (Danaher);Siemens Healthineers; Abbott; Diasorin S.p.a.; Thermo Fisher Scientific Inc.; Qiagen; BIOMÉRIEUX; Hologic Inc.; Bio Rad Laboratories; Quidel Corporation; EKF Diagnostics; SEKISUI Diagnostics; DiaSys-Diagnostic Systems GmbH; InBios International; Inc.; Jiangsu Mole Bioscience Co.; Ltd.; ACON Laboratories; Inc.; Visby Medical; Inc.; UNIMA; INC. |
Point-of-Care testing (POCT) refers to medical diagnostic testing that is performed near the patient, usually at the bedside or in a doctor's office, rather than in a central laboratory. The goal of POCT is to provide rapid and accurate diagnostic results that can guide clinical decision-making in real-time.
The world is seeing rapid advancements in a wide range of digital health technologies, including portable and ingestible devices; mobile health apps; artificial intelligence (AI); robots used in healthcare; 3D organ printing; block chain; telemedicine; machine learning; genome research; drones; augmented and virtual reality; and electronic records. However, the market is also shifting to digitalization, so the influx of digital health technologies is a prominent driver for point-of-care diagnostic market.
Accelerating the adoption of proven digital health technologies and advancing their embedding into routine care operations has the potential to revolutionize human health by boosting efficacy, driving costs down, and increasing access to and capacity for care delivery.
New product launches and approvals such as Lab-on-a-chip technology is one of the main drivers of POCT.
Overall, the increasing adoption of latest technologies and new product launches and approvals is likely to boost the market in the coming years.
Sales of the global point-of-care diagnostics market grew at a CAGR of 6.2% between 2012 to 2022. Global point-of-care diagnostics market contributes 40.0% revenue share to the global in-vitro diagnostics market valued at USD 91.2 Billion in 2022.
The increasing prevalence of Infectious diseases has resulted in higher uptake of POC diagnostic options such as Glucose and Hb1Ac testing. Because of their easy availability and rapid diagnosis, point-of-care diagnostics are typically the first form of testing recommended worldwide.
A significant advance has been made in the effort to identify SARS-CoV-2 coronavirus patients with the addition of saliva samples for the purpose of coronavirus identification. Governments concentrated on raising knowledge about COVID-19 testing during the COVID-19 epidemic to ensure an early identification of the illness. As a result of such initiatives, people become more knowledgeable of Point-of-Care testing for the diagnosis of coronavirus.
Creating awareness about diseases is an essential aspect of early detection and screening. If the public has a general understanding of diseases and symptoms, action plans can be better implemented. On the other hand, if there is a lack of awareness, it stops people from taking preventive measures or availing treatments.
Considering this, FMI expects the global market to grow at a CAGR of 6.8% through the forecasted years.
There is a lack of expansion of biotechnology & pharmaceutical Industries regarding point-of-care diagnostics. Biopharmaceuticals are one of modern science's most technically advanced and exquisite achievements.
Pharmaceutical companies are putting in a lot of effort to produce medications and lifesaving vaccines and biologicals for the entire world. When the pharmaceutical sector employs biotechnological advancements and advanced processes, the result is better and faster drug delivery. Biotechnology has aided the pharmaceutical sector in the correct manufacturing of vaccines and medications.
The pharmaceutical sector intends to establish products that support the treatment of various diseases. This may result in pharma companies manufacturing point-of-Care (POC) devices.
While greater investment for innovative products is required for the growth of the market, the healthcare infrastructure can have a substantial impact on market expansion. Most healthcare authorities have recently committed increased financing for the development and enhancement of their healthcare infrastructure as a result of the COVID-19 pandemic. The development of Point-of-Care diagnostics kits and their production need more investment.
Overall, healthcare infrastructure for POCT is complex and evolving, and it is important that companies stay abreast of regulatory changes and work closely with regulators to ensure compliance. However, regulatory initiatives that promote safe and effective pain management can create growth opportunities for the POCT market, especially for companies that offer innovative solutions.
Increased testing of point-of-care diagnosis in patients will pave the way for new technology and treatment options, ultimately leading more improvement in healthcare infrastructure and growth in number of manufacturing facilities.
Point-of-Care tests in some therapy areas have become more accurate (e.g., glucose testing). Overall, POC tests and rapid tests tend to remain less accurate compared to tests run in a laboratory. Accuracy is essential in medical testing, because an incorrect diagnosis can lead to inappropriate treatment, which can have serious consequences for patients. Inaccurate POC results can lead to false positives or false negatives, which can result in unnecessary treatment or missed diagnosis, respectively.
Inaccurate POCT results can also lead to mistrust in the technology, which can impact the adoption and utilization of POCT products. Healthcare providers may be hesitant to rely on POCT if they have concerns about its accuracy and reliability.
The cost of tests and a lack of trust in POC/ rapid testing are major concerns around the globe. The cost of point-of-care kits or devices is very high as compared to laboratory tests, which is compounded by the lower level of accuracy offered by the former.
Due to financial constraints, academic research laboratories are often unable to purchase expensive equipment. The overall cost of these instruments increases as a result of maintenance costs and other indirect expenses. Thus, the higher cost associated with the equipment and other factors causing unaffordability for the laboratories might hamper the market growth.
These factors are expected to hamper revenue growth of the global market over the forecast period.
USA dominated the global market in 2022 and is further expected to register growth rate at CAGR of 6.8%.
Diagnostic techniques, such as rapid testing or POCT like COVID-19 testing, glucose testing, and allergy tests, etc., has seen a high rate of patient acceptance as a result of the high prevalence. Awareness campaigns and strategic conferences with focus on point-of-care technologies for healthcare sector, has been undertaken by various associations in USA
In May 2022, American Association for Clinical Chemistry, organized a Point-of-Care testing boot camp for POCT professionals and experts in the lab medicine community.
Why is Germany considered to be a Lucrative Market for Point-of-Care Diagnostics?
The general physicians in primary care settings in Germany highly prefer POCTs as a useful diagnostic tool. There are numerous POCTs available in the German market. In the past few years, due to COVID-19 point-of-care diagnostics has been of tremendous importance as first line of defense for testing purpose.
The safe and successful use of point-of-care diagnostics in Germany is likely to influence other European countries to also opt for this method, ultimately resulting in market expansion.
China is projected to be the most attractive market in the east Asia point-of-care diagnostics and is expected to grow over a significant CAGR of 9.0% over the forecast period.
Point-of-care diagnostics market in China is expected to grow significantly in the coming years due to several factors.
One of the main factors driving the growth of the point-of-care diagnostics market in China is the increasing awareness of the condition among the general public and healthcare professionals. As more people become aware of the POC testing, they are more likely to adapt to the testing method, which is leading to increased demand for testing for Point-of-care diagnostics.
Another factor contributing to the growth of the Chinese market is the increasing availability of advanced medical technologies. China has made significant investments in its healthcare infrastructure, and many new hospitals and clinics have been built in recent years.
The COVID-19 testing diagnostic segment held the major chunk of about 15.1% in global market by the end of 2022. However, food sensitivity testing is the most lucrative segment over the forecast period due to increase in food allergic cases. Many of allergic reactions require rapid diagnosis that’s where point-of-care diagnostics plays a significant role.
Nasal swabs segment accounted for revenue share of 28.4% in the global market at the end of 2022.
A nasopharyngeal swab, one type of nasal swab, is a test used to look for bacteria or viruses that cause respiratory infections. Your healthcare provider uses a swab to take a small sample of cells from your nasopharynx, the top part of your nose and throat.
Overall, nasal swabs offers a convenient sample type for point-of-care diagnostics for sample withdrawal, making it the largest sample type for this segment.
Handheld POC Monitoring Devices segment accounted for revenue share of 41.3% in the global market at the end of 2022.
Handheld POC monitoring devices can be used to monitor a wide range of medical conditions, such as diabetes, cardiovascular disease, and infectious diseases. For example, a handheld blood glucose meter can be used by patients with diabetes to monitor their blood sugar levels, while a handheld device that measures blood pressure can be used to monitor patients with hypertension.
Overall, Handheld POC Monitoring Devices offers a convenient Product type for Global Point-of-Care diagnostics treating products, making it the largest Product for this segment.
Hospitals held the major chunk of about 27.7% in global market by the end of 2022.
Hospitals offers a convenient end user for POCT market conducting POC tests, making it the dominant end user for this segment. Hospitals segment is set to be highly lucrative in the upcoming years due to ease and access of POCT.
Collaboration are the top strategy being adopted by leading players to expand their product portfolio, their customer base as well as maintain their foothold in the market.
For instance:
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the Point-of-care Diagnostics Market space, which are available in the full report
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2012 to 2022 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, UK, France, Italy, Spain, Russia, BENELUX, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, Türkiye, South Africa, and GCC Countries |
| Key Segments Covered | Test Type, Sample, Product, End User, Region |
| Key Companies Profiled | F. Hoffmann-La Roche Ltd; Becton Dickinson & Company; Cepheid (Danaher); Siemens Healthineers; Abbott; Diasorin S.p.a.; Thermo Fisher Scientific Inc.; Qiagen; BIOMÉRIEUX; Hologic Inc.; Bio Rad Laboratories; Quidel Corporation; EKF Diagnostics; SEKISUI Diagnostics; DiaSys-Diagnostic Systems GmbH; InBios International, Inc.; Jiangsu Mole Bioscience Co., Ltd.; ACON Laboratories, Inc.; Visby Medical, Inc.; UNIMA, INC. |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
Table 01: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Test Type
Table 02: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 03: Global Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 04: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample
Table 05: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 06: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Region
Table 07: North America Market Value (US$ Million) Analysis 2012-2022 and Forecast 2023 to 2033, by Country
Table 08: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Test Type
Table 09: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 10: North America Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 11: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample
Table 12: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 13: Latin America Market Value (US$ Million) Analysis 2012-2022 and Forecast 2023 to 2033, by Country
Table 14: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Test Type
Table 15: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 16: Latin America Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 17: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample
Table 18: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 19: Europe Market Value (US$ Million) Analysis 2012-2022 and Forecast 2023 to 2033, by Country
Table 20: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Test Type
Table 21: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 22: Europe Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 23: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample
Table 24: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 25: South Asia Market Value (US$ Million) Analysis 2012-2022 and Forecast 2023 to 2033, by Country
Table 26: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Test Type
Table 27: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 28: South Asia Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 29: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample
Table 30: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 31: East Asia Market Value (US$ Million) Analysis 2012-2022 and Forecast 2023 to 2033, by Country
Table 32: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Test Type
Table 33: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 34: East Asia Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 35: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample
Table 36: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 37: Oceania Market Value (US$ Million) Analysis 2012-2022 and Forecast 2023 to 2033, by Country
Table 38: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Test Type
Table 39: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 40: Oceania Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 41: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample
Table 42: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 43: Middle East and Africa Market Value (US$ Million) Analysis 2012-2022 and Forecast 2023 to 2033, by Country
Table 44: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Test Type
Table 45: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 46: Middle East and Africa Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 47: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample
Table 48: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Figure 01: Global Market Volume (Units), 2012 to 2022
Figure 02: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis,
Figure 03: Global Point-of-Care Diagnostics, Pricing Analysis per unit (US$), in 2022
Figure 04: Global Point-of-Care Diagnostics, Pricing Forecast per unit (US$), in 2032
Figure 05: Global Market Value (US$ Million) Analysis, 2012 to 2022
Figure 06: Global Market Forecast & Y-o-Y Growth, 2023 to 2033
Figure 07: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2022-2033
Figure 08: Global Market Value Share (%) Analysis 2023 and 2033, by Test Type
Figure 09: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Test Type
Figure 10: Global Market Attractiveness Analysis 2023 to 2033, by Test Type
Figure 11: Global Market Value Share (%) Analysis 2023 and 2033, by Sample
Figure 12: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Sample
Figure 13: Global Market Attractiveness Analysis 2023 to 2033, by Sample
Figure 14: Global Market Value Share (%) Analysis 2023 and 2033, by Product
Figure 15: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Product
Figure 16: Global Market Attractiveness Analysis 2023 to 2033, by Product
Figure 17: Global Market Value Share (%) Analysis 2023 and 2033, by End User
Figure 18: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by End User
Figure 19: Global Market Attractiveness Analysis 2023 to 2033, by End User
Figure 20: Global Market Value Share (%) Analysis 2023 and 2033, by Region
Figure 21: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Region
Figure 22: Global Market Attractiveness Analysis 2023 to 2033, by Region
Figure 23: North America Market Value (US$ Million) Analysis, 2012 to 2022
Figure 24: North America Market Value (US$ Million) Forecast, 2023 to 2033
Figure 25: North America Market Value Share, by Test Type (2023 E)
Figure 26: North America Market Value Share, by Sample (2023 E)
Figure 27: North America Market Value Share, by Product (2023 E)
Figure 28: North America Market Value Share, by End User (2023 E)
Figure 29: North America Market Value Share, by Country (2023 E)
Figure 30: North America Market Attractiveness Analysis by Test Type, 2023 to 2033
Figure 31: North America Market Attractiveness Analysis by Sample, 2023 to 2033
Figure 32: North America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 33: North America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 34: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 35: USA Market Value Proportion Analysis, 2022
Figure 36: Global Vs. USA Growth Comparison, 2022 to 2033
Figure 37: USA Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 38: USA Market Share Analysis (%) by Sample, 2022 & 2033
Figure 39: USA Market Share Analysis (%) by Product, 2022 & 2033
Figure 40: USA Market Share Analysis (%) by End User, 2022 & 2033
Figure 41: Canada Market Value Proportion Analysis, 2022
Figure 42: Global Vs. Canada. Growth Comparison, 2022 to 2033
Figure 43: Canada Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 44: Canada Market Share Analysis (%) by Sample, 2022 & 2033
Figure 45: Canada Market Share Analysis (%) by Product, 2022 & 2033
Figure 46: Canada Market Share Analysis (%) by End User, 2022 & 2033
Figure 47: Latin America Market Value (US$ Million) Analysis, 2012 to 2022
Figure 48: Latin America Market Value (US$ Million) Forecast, 2023 to 2033
Figure 49: Latin America Market Value Share, by Test Type (2023 E)
Figure 50: Latin America Market Value Share, by Sample (2023 E)
Figure 51: Latin America Market Value Share, by Product (2023 E)
Figure 52: Latin America Market Value Share, by End User (2023 E)
Figure 53: Latin America Market Value Share, by Country (2023 E)
Figure 54: Latin America Market Attractiveness Analysis by Test Type, 2023 to 2033
Figure 55: Latin America Market Attractiveness Analysis by Sample, 2023 to 2033
Figure 56: Latin America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 57: Latin America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 58: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 59: Mexico Market Value Proportion Analysis, 2022
Figure 60: Global Vs Mexico Growth Comparison, 2022 to 2033
Figure 61: Mexico Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 62: Mexico Market Share Analysis (%) by Sample, 2022 & 2033
Figure 63: Mexico Market Share Analysis (%) by Product, 2022 & 2033
Figure 64: Mexico Market Share Analysis (%) by End User, 2022 & 2033
Figure 65: Brazil Market Value Proportion Analysis, 2022
Figure 66: Global Vs. Brazil. Growth Comparison, 2022 to 2033
Figure 67: Brazil Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 68: Brazil Market Share Analysis (%) by Sample, 2022 & 2033
Figure 69: Brazil Market Share Analysis (%) by Product, 2022 & 2033
Figure 70: Brazil Market Share Analysis (%) by End User, 2022 & 2033
Figure 71: Argentina Market Value Proportion Analysis, 2022
Figure 72: Global Vs Argentina Growth Comparison, 2022 to 2033
Figure 73: Argentina Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 74: Argentina Market Share Analysis (%) by Sample, 2022 & 2033
Figure 75: Argentina Market Share Analysis (%) by Product, 2022 & 2033
Figure 76: Argentina Market Share Analysis (%) by End User, 2022 & 2033
Figure 77: Europe Market Value (US$ Million) Analysis, 2012 to 2022
Figure 78: Europe Market Value (US$ Million) Forecast, 2023 to 2033
Figure 79: Europe Market Value Share, by Test Type (2023 E)
Figure 80: Europe Market Value Share, by Sample (2023 E)
Figure 81: Europe Market Value Share, by Product (2023 E)
Figure 82: Europe Market Value Share, by End User (2023 E)
Figure 83: Europe Market Value Share, by Country (2023 E)
Figure 84: Europe Market Attractiveness Analysis by Test Type, 2023 to 2033
Figure 85: Europe Market Attractiveness Analysis by Sample, 2023 to 2033
Figure 86: Europe Market Attractiveness Analysis by Product, 2023 to 2033
Figure 87: Europe Market Attractiveness Analysis by End User, 2023 to 2033
Figure 88: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 89: UK Market Value Proportion Analysis, 2022
Figure 90: Global Vs. UK Growth Comparison, 2022 to 2033
Figure 91: UK Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 92: UK Market Share Analysis (%) by Sample, 2022 & 2033
Figure 93: UK Market Share Analysis (%) by Product, 2022 & 2033
Figure 94: UK Market Share Analysis (%) by End User, 2022 & 2033
Figure 95: Germany Market Value Proportion Analysis, 2022
Figure 96: Global Vs. Germany Growth Comparison, 2022 to 2033
Figure 97: Germany Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 98: Germany Market Share Analysis (%) by Sample, 2022 & 2033
Figure 99: Germany Market Share Analysis (%) by Product, 2022 & 2033
Figure 100: Germany Market Share Analysis (%) by End User, 2022 & 2033
Figure 101: Italy Market Value Proportion Analysis, 2022
Figure 102: Global Vs. Italy Growth Comparison, 2022 to 2033
Figure 103: Italy Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 104: Italy Market Share Analysis (%) by Sample, 2022 & 2033
Figure 105: Italy Market Share Analysis (%) by Product, 2022 & 2033
Figure 106: Italy Market Share Analysis (%) by End User, 2022 & 2033
Figure 107: France Market Value Proportion Analysis, 2022
Figure 108: Global Vs France Growth Comparison, 2022 to 2033
Figure 109: France Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 110: France Market Share Analysis (%) by Sample, 2022 & 2033
Figure 111: France Market Share Analysis (%) by Product, 2022 & 2033
Figure 112: France Market Share Analysis (%) by End User, 2022 & 2033
Figure 113: Spain Market Value Proportion Analysis, 2022
Figure 114: Global Vs Spain Growth Comparison, 2022 to 2033
Figure 115: Spain Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 116: Spain Market Share Analysis (%) by Sample, 2022 & 2033
Figure 117: Spain Market Share Analysis (%) by Product, 2022 & 2033
Figure 118: Spain Market Share Analysis (%) by End User, 2022 & 2033
Figure 119: Russia Market Value Proportion Analysis, 2022
Figure 120: Global Vs Russia Growth Comparison, 2022 to 2033
Figure 121: Russia Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 122: Russia Market Share Analysis (%) by Sample, 2022 & 2033
Figure 123: Russia Market Share Analysis (%) by Product, 2022 & 2033
Figure 124: Russia Market Share Analysis (%) by End User, 2022 & 2033
Figure 125: BENELUX Market Value Proportion Analysis, 2022
Figure 126: Global Vs BENELUX Growth Comparison, 2022 to 2033
Figure 127: BENELUX Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 128: BENELUX Market Share Analysis (%) by Sample, 2022 & 2033
Figure 129: BENELUX Market Share Analysis (%) by Product, 2022 & 2033
Figure 130: BENELUX Market Share Analysis (%) by End User, 2022 & 2033
Figure 131: East Asia Market Value (US$ Million) Analysis, 2012 to 2022
Figure 132: East Asia Market Value (US$ Million) Forecast, 2023 to 2033
Figure 133: East Asia Market Value Share, by Test Type (2023 E)
Figure 134: East Asia Market Value Share, by Sample (2023 E)
Figure 135: East Asia Market Value Share, by Product (2023 E)
Figure 136: East Asia Market Value Share, by End User (2023 E)
Figure 137: East Asia Market Value Share, by Country (2023 E)
Figure 138: East Asia Market Attractiveness Analysis by Test Type, 2023 to 2033
Figure 139: East Asia Market Attractiveness Analysis by Sample, 2023 to 2033
Figure 140: East Asia Market Attractiveness Analysis by Product, 2023 to 2033
Figure 141: East Asia Market Attractiveness Analysis by End User, 2023 to 2033
Figure 142: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 143: China Market Value Proportion Analysis, 2022
Figure 144: Global Vs. China Growth Comparison, 2022 to 2033
Figure 145: China Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 146: China Market Share Analysis (%) by Sample, 2022 & 2033
Figure 147: China Market Share Analysis (%) by Product, 2022 & 2033
Figure 148: China Market Share Analysis (%) by End User, 2022 & 2033
Figure 149: Japan Market Value Proportion Analysis, 2022
Figure 150: Global Vs. Japan Growth Comparison, 2022 to 2033
Figure 151: Japan Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 152: Japan Market Share Analysis (%) by Sample, 2022 & 2033
Figure 153: Japan Market Share Analysis (%) by Product, 2022 & 2033
Figure 154: Japan Market Share Analysis (%) by End User, 2022 & 2033
Figure 155: South Korea Market Value Proportion Analysis, 2022
Figure 156: Global Vs South Korea Growth Comparison, 2022 to 2033
Figure 157: South Korea Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 158: South Korea Market Share Analysis (%) by Sample, 2022 & 2033
Figure 159: South Korea Market Share Analysis (%) by Product, 2022 & 2033
Figure 160: South Korea Market Share Analysis (%) by End User, 2022 & 2033
Figure 161: South Asia Market Value (US$ Million) Analysis, 2012 to 2022
Figure 162: South Asia Market Value (US$ Million) Forecast, 2023 to 2033
Figure 163: South Asia Market Value Share, by Test Type (2023 E)
Figure 164: South Asia Market Value Share, by Sample (2023 E)
Figure 165: South Asia Market Value Share, by Product (2023 E)
Figure 166: South Asia Market Value Share, by End User (2023 E)
Figure 167: South Asia Market Value Share, by Country (2023 E)
Figure 168: South Asia Market Attractiveness Analysis by Test Type, 2023 to 2033
Figure 169: South Asia Market Attractiveness Analysis by Sample, 2023 to 2033
Figure 170: South Asia Market Attractiveness Analysis by Product, 2023 to 2033
Figure 171: South Asia Market Attractiveness Analysis by End User, 2023 to 2033
Figure 172: South Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 173: India Market Value Proportion Analysis, 2022
Figure 174: Global Vs. India Growth Comparison, 2022 to 2033
Figure 175: India Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 176: India Market Share Analysis (%) by Sample, 2022 & 2033
Figure 177: India Market Share Analysis (%) by Product, 2022 & 2033
Figure 178: India Market Share Analysis (%) by End User, 2022 & 2033
Figure 179: Indonesia Market Value Proportion Analysis, 2022
Figure 180: Global Vs. Indonesia Growth Comparison, 2022 to 2033
Figure 181: Indonesia Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 182: Indonesia Market Share Analysis (%) by Sample, 2022 & 2033
Figure 183: Indonesia Market Share Analysis (%) by Product, 2022 & 2033
Figure 184: Indonesia Market Share Analysis (%) by End User, 2022 & 2033
Figure 185: Malaysia Market Value Proportion Analysis, 2022
Figure 186: Global Vs. Malaysia Growth Comparison, 2022 to 2033
Figure 187: Malaysia Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 188: Malaysia Market Share Analysis (%) by Sample, 2022 & 2033
Figure 189: Malaysia Market Share Analysis (%) by Product, 2022 & 2033
Figure 190: Malaysia Market Share Analysis (%) by End User, 2022 & 2033
Figure 191: Thailand Market Value Proportion Analysis, 2022
Figure 192: Global Vs. Thailand Growth Comparison, 2022 to 2033
Figure 193: Thailand Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 194: Thailand Market Share Analysis (%) by Sample, 2022 & 2033
Figure 195: Thailand Market Share Analysis (%) by Product, 2022 & 2033
Figure 196: Thailand Market Share Analysis (%) by End User, 2022 & 2033
Figure 197: Oceania Market Value (US$ Million) Analysis, 2012 to 2022
Figure 198: Oceania Market Value (US$ Million) Forecast, 2023 to 2033
Figure 199: Oceania Market Value Share, by Test Type (2023 E)
Figure 200: Oceania Market Value Share, by Sample (2023 E)
Figure 201: Oceania Market Value Share, by Product (2023 E)
Figure 202: Oceania Market Value Share, by End User (2023 E)
Figure 203: Oceania Market Value Share, by Country (2023 E)
Figure 204: Oceania Market Attractiveness Analysis by Test Type, 2023 to 2033
Figure 205: Oceania Market Attractiveness Analysis by Sample, 2023 to 2033
Figure 206: Oceania Market Attractiveness Analysis by Product, 2023 to 2033
Figure 207: Oceania Market Attractiveness Analysis by End User, 2023 to 2033
Figure 208: Oceania Market Attractiveness Analysis by Country, 2023 to 2033
Figure 209: Australia Market Value Proportion Analysis, 2022
Figure 210: Global Vs. Australia Growth Comparison, 2022 to 2033
Figure 211: Australia Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 212: Australia Market Share Analysis (%) by Sample, 2022 & 2033
Figure 213: Australia Market Share Analysis (%) by Product, 2022 & 2033
Figure 214: Australia Market Share Analysis (%) by End User, 2022 & 2033
Figure 215: New Zealand Market Value Proportion Analysis, 2022
Figure 216: Global Vs New Zealand Growth Comparison, 2022 to 2033
Figure 217: New Zealand Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 218: New Zealand Market Share Analysis (%) by Sample, 2022 & 2033
Figure 219: New Zealand Market Share Analysis (%) by Product, 2022 & 2033
Figure 220: New Zealand Market Share Analysis (%) by End User, 2022 & 2033
Figure 221: Middle East and Africa Market Value (US$ Million) Analysis, 2012 to 2022
Figure 222: Middle East and Africa Market Value (US$ Million) Forecast, 2023 to 2033
Figure 223: Middle East and Africa Market Value Share, by Test Type (2023 E)
Figure 224: Middle East and Africa Market Value Share, by Sample (2023 E)
Figure 225: Middle East and Africa Market Value Share, by Product (2023 E)
Figure 226: Middle East and Africa Market Value Share, by End User (2023 E)
Figure 227: Middle East and Africa Market Value Share, by Country (2023 E)
Figure 228: Middle East and Africa Market Attractiveness Analysis by Test Type, 2023 to 2033
Figure 229: Middle East and Africa Market Attractiveness Analysis by Sample, 2023 to 2033
Figure 230: Middle East and Africa Market Attractiveness Analysis by Product, 2023 to 2033
Figure 231: Middle East and Africa Market Attractiveness Analysis by End User, 2023 to 2033
Figure 232: Middle East and Africa Market Attractiveness Analysis by Country, 2023 to 2033
Figure 233: GCC Country Market Value Proportion Analysis, 2022
Figure 234: Global Vs GCC Country Growth Comparison, 2022 to 2033
Figure 235: GCC Country Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 236: GCC Country Market Share Analysis (%) by Sample, 2022 & 2033
Figure 237: GCC Country Market Share Analysis (%) by Product, 2022 & 2033
Figure 238: GCC Country Market Share Analysis (%) by End User, 2022 & 2033
Figure 239: Türkiye Market Value Proportion Analysis, 2022
Figure 240: Global Vs. Türkiye Growth Comparison, 2022 to 2033
Figure 241: Türkiye Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 242: Türkiye Market Share Analysis (%) by Sample, 2022 & 2033
Figure 243: Türkiye Market Share Analysis (%) by Product, 2022 & 2033
Figure 244: Türkiye Market Share Analysis (%) by End User, 2022 & 2033
Figure 245: South Africa Market Value Proportion Analysis, 2022
Figure 246: Global Vs. South Africa Growth Comparison, 2022 to 2033
Figure 247: South Africa Market Share Analysis (%) by Test Type, 2022 & 2033
Figure 248: South Africa Market Share Analysis (%) by Sample, 2022 & 2033
Figure 249: South Africa Market Share Analysis (%) by Product, 2022 & 2033
Figure 250: South Africa Market Share Analysis (%) by End User, 2022 & 2033
The growth potential of the market is 6.8% through 2033.
The United States and Germany are projected to emerge as lucrative markets.
Hospitals offer a convenient end user for the POCT market conducting POC tests, making it the dominant end user.
Handheld POC Monitoring Devices accounted for a revenue share of 41.3% in 2022.
Efforts to produce medications and lifesaving vaccines and biologicals for the entire world drive sales.
Explore In-vitro Diagnostics Devices Insights
Point-of-Care Diagnostics Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
